SEC Filings

Form 8-K
IOVANCE BIOTHERAPEUTICS, INC. filed this Form 8-K on 10/12/2018
Document Outline
Entire Document (293.6 KB)
Subdocument 1 - 8-K - FORM 8-K
Page 1 - UNITED STATES
Page 2 - Forward-Looking Statements
Page 3 - EXHIBIT
Page 4 - SIGNATURES
Subdocument 2 - EX-1.1 - EXHIBIT 1.1
Page 1 - Exhibit 1.1
Page 2 - Exchange Act ) that is or is deemed to be incorporated by reference in the Registration Statement, t
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - Section 2. Purchase, Sale and Delivery of the Offered Shares.
Page 14 - N/A
Page 15 - Section 3. Additional Covenants of the Company.
Page 16 - N/A
Page 17 - N/A
Page 18 - N/A
Page 19 - N/A
Page 20 - Section 4. Payment of Expenses. The Company agrees to pay all costs, fees and expenses incurred in c
Page 21 - N/A
Page 22 - Section 7. Reimbursement of Underwriters Expenses. If this Agreement is terminated by the Representa
Page 23 - Section 8. Effectiveness of this Agreement. This Agreement shall become effective upon the execution
Page 24 - N/A
Page 25 - Section 10. Contribution. If the indemnification provided for in Section 9 is for any reason held to
Page 26 - Section 11. Default of One or More of the Several Underwriters. If, on the First Closing Date or any
Page 27 - Underwriter shall be deemed to include any person substituted for a defaulting Underwriter under thi
Page 28 - Section 15. Notices. All communications hereunder shall be in writing and shall be mailed, hand deli
Page 29 - Section 18. Governing Law Provisions. This Agreement shall be governed by and construed in accordanc
Page 30 - JEFFERIES LLC
Page 31 - Schedule A
Page 32 - Exhibit A
Page 33 - Exhibit B
Page 34 - Exhibit C
Page 35 - N/A
Page 36 - N/A
Page 37 - N/A
Page 38 - N/A
Page 39 - Exhibit D
Subdocument 3 - EX-5.1 - EXHIBIT 5.1
Page 1 - N/A
Subdocument 4 - EX-99.1 - EXHIBIT 99.1
Page 1 - Exhibit 99.1
Page 2 - About Iovance Biotherapeutics, Inc.
Subdocument 5 - EX-99.2 - EXHIBIT 99.2
Page 1 - Exhibit 99.2
Page 2 - About Iovance Biotherapeutics, Inc.
Page 3 - Investor Relations Contact: